Literature DB >> 7928626

HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA).

K Hayashi1, N Ohara, T R Koirala, H Ino, H L Chen, N Teramoto, E Kondo, T Yoshino, K Takahashi, M Yamada.   

Abstract

Lymphoma induction in rabbits by an unknown factor derived from an HTLV-II-producing simian (Cynomolgus) leukocyte cell line (Si-IIA) is reported. Thirteen of 17 male Japanese white rabbits (76%) inoculated intravenously with Si-IIA cells developed malignant lymphoma including Hodgkin-like lymphoma between 62 and 167 days after inoculation. Histologically, there was extensive diffuse or nodular infiltration of either large cell type or mixed type lymphoma cells in many organs, frequently involving the spleen, liver, lymph nodes and kidneys, and less frequently the thymus, bone marrow, lungs, heart, skin and gastrointestinal tract. Hodgkin-like lymphoma was also observed in two rabbits. Chromosomal analysis of five cell lines established from tumor-bearing rabbits revealed the male rabbit karyotype. The immunophenotype of these tumor cells was usually T-cell (CD5+ or -, RT1+, RT2+ or -, CD45+, CD4-, RABELA- and MHC class II-DQ+) except for Hodgkin-like lymphoma cells which expressed only CD45. However, integration of the HTLV-II provirus genome could not be demonstrated in the tumor tissues or any of the rabbit cell lines by polymerase chain reaction or Southern blot analysis. Moreover, no lymphoma was induced by inoculation of HTLV-IIC, MOT (other HTLV-II-producing human cell lines) or TALL-1 (control). Two of four rabbits injected with cell-free pellets from Si-IIA cultures died of malignant lymphoma (15-20 days). Five irradiated rabbit cell lines were inoculated but only one (Ra-SLN) induced lymphoma in 1 of 3 rabbits at 27 days. Neither Herpesvirus saimiri nor Herpesvirus ateles (simian oncogenic viruses) was detected in Si-IIA cells by immunofluorescence testing. These data suggest that the high rate of lymphoma induction in rabbits may be caused not by only HTLV-II or well known simian oncogenic viruses, but rather by an unknown passenger agent derived from Si-IIA or HTLV-IIA, with which Si-IIA was established.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928626      PMCID: PMC5919558          DOI: 10.1111/j.1349-7006.1994.tb02952.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  HTLV-II in patients with HTLV-I-associated myelopathy.

Authors:  J Kira; Y Koyanagi; T Hamakado; Y Itoyama; N Yamamoto; I Goto
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

2.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  A human T cell line with an abnormal trisomy 2 karyotype established by coculture of peripheral lymphocytes with an HTLV-II-infected simian leukocyte cell line.

Authors:  N Ohara; K Hayashi; K Miyamoto; N Tomita; K Fujiwara; E Kondo; K Takahashi; Y Ohtsuki; T Akagi
Journal:  Acta Pathol Jpn       Date:  1993-05

4.  A novel monoclonal antibody specifically reactive with human T-lymphotropic virus type-II (HTLV-II) envelope protein.

Authors:  N Ohara; K Hayashi; K Takahashi; K Miyamoto; T Akagi
Journal:  Int J Cancer       Date:  1993-07-09       Impact factor: 7.396

5.  Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia.

Authors:  T P Loughran; T Coyle; M P Sherman; G Starkebaum; G D Ehrlich; F W Ruscetti; B J Poiesz
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

6.  Chromosome abnormalities of leukemia cells in adult patients with T-cell leukemia.

Authors:  K Miyamoto; N Tomita; A Ishii; H Nonaka; T Kondo; T Tanaka; K Kitajima
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

7.  HTLV-II-specific antisera raised in rabbits immunized with a synthetic peptide of HTLV-II envelope protein.

Authors:  K Hayashi; N Ohara; K Fujiwara; H J Jeon; T R Koirala; K Takahashi; T Akagi; N Tomita; K Miyamoto
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1992

8.  Infectious transmission of human T-cell lymphotropic virus type II in rabbits.

Authors:  G L Cockerell; M G Weiser; J Rovnak; B Wicks-Beard; B Roberts; A Post; I S Chen; M D Lairmore
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

9.  Isolation and characterization of a human T cell leukemia virus type II from a hemophilia-A patient with pancytopenia.

Authors:  V S Kalyanaraman; R Narayanan; P Feorino; R B Ramsey; E L Palmer; T Chorba; S McDougal; J P Getchell; B Holloway; A K Harrison
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

10.  Identification of human T cell leukemia virus type IIb infection in the Wayu, an aboriginal population of Colombia.

Authors:  S Ijichi; K Tajima; V Zaninovic; F E Leon-S; Y Katahira; S Sonoda; T Miura; M Hayami; W W Hall
Journal:  Jpn J Cancer Res       Date:  1993-12
View more
  2 in total

1.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.